Discover pharmaceutical science, research, innovations, and global health impact.
Pharmaceutical
AbbVie has announced plans to invest $195 million in its manufacturing facility in North Chicago, Illinois, to enhance the production of active pharmaceutical ingredients (API) within the United States. The move is part of AbbVie’s broader strategy to strengthen domestic manufacturing capabilities, following its earlier pledge to invest more
Pharmaceutical
Varda Space is pushing the boundaries of pharmaceutical production by taking the process out of Earth’s gravity well and into orbit. The company announced a $187 million Series C funding round on Thursday to accelerate its mission of using space as a unique environment for drug manufacturing. With gravity
Healthcare
In a bold move to solidify its international presence, Hims & Hers Health announced Tuesday it will acquire Zava, a prominent European telehealth platform. The acquisition marks a pivotal step in the U.S.-based company's strategy to expand beyond domestic borders and tap into growing demand for
Biotechnology
Pharmaceutical giant Regeneron announced Monday that it will acquire genetic testing company 23andMe for $256 million, following a court-supervised bankruptcy auction. The deal, if approved, will grant Regeneron ownership of 23andMe’s genomics service and a massive trove of personal and genetic data from roughly 15 million customers. The acquisition
E-commerce
Amazon is stepping further into the healthcare space — this time, with a focus on pets. The retail giant announced a new partnership with Vetsource, an online pet pharmacy, to offer prescription medications for cats and dogs directly through its U.S. storefront. The move marks a significant expansion of Amazon’
Biotechnology
Biotech startup NewLimit, which is focused on extending healthy human lifespan through cellular reprogramming, has raised a $130 million Series B round led by Kleiner Perkins. The round also included new investors Nat Friedman, Daniel Gross, and Khosla Ventures, along with returning backers like Founders Fund, Dimension Capital, Elad Gil,
Pharmaceutical
Merck is making a $1 billion bet on American manufacturing with plans to build a major production facility in Wilmington, Delaware. The 470,000-square-foot site will be dedicated to producing Keytruda, Merck’s blockbuster cancer immunotherapy drug, for U.S. patients. This marks the company’s first domestic site devoted
Pharmaceutical
Swiss pharmaceutical giant Roche announced a massive $50 billion investment in the United States over the next five years, reinforcing its commitment to the American market amid rising concerns about looming White House tariffs on imported pharmaceutical goods. The investment will generate over 12,000 jobs, with 1,000 directly
Pharmaceutical
In a bold move signaling its deepening commitment to the U.S. market, Swiss pharmaceutical giant Novartis announced plans to invest $23 billion over the next five years to dramatically expand its American footprint. The investment includes the construction of six new manufacturing facilities, expansion of three existing ones, and
Business Insights
WW International, better known as WeightWatchers, is preparing to file for bankruptcy in the coming months as it grapples with mounting debt and a rapidly shifting weight-loss landscape. The company, once a dominant name in health and wellness, is in discussions to hand over control of the business to its
Biotechnology
Isomorphic Labs, the artificial intelligence-driven drug discovery startup spun out of DeepMind, has secured $600 million in its first-ever external funding round. The financing, led by Thrive Capital with participation from Alphabet and its venture arm GV, marks a significant milestone for the Alphabet-owned company as it scales its efforts
Retail
Walgreens, one of the most recognizable names in American retail pharmacy, is going private after nearly a century as a publicly traded company. The struggling drugstore chain announced on Thursday that it has reached a deal with private equity firm Sycamore Partners in a transaction valued at up to $23.